Seattle-based medical device company Bardy Diagnostics today announced a $35.5 million funding round led by River Cities Capital Fund. The company makes the Carnation Ambulatory Monitor (CAM), which ...
Danaher operates across biotechnology, diagnostics, and life sciences markets. Explore recent FDA developments, healthcare ...
LG Electronics (LG) announced it is accelerating its B2B medical device business, expanding its lineup of diagnostic monitors with the new 21HQ613D-B. Per the company, the new model was recently ...
In another deal for cardiac monitoring, Hillrom (NYSE: HRC) will buy Seattle-based startup Bardy Diagnostics for $375 million. The company, which was founded in 2013 by electrophysiologist Dr. Gust ...
In a recent review article published in the journal Nature Medicine Intelligence, scientists at the California Institute of Technology discussed the involvement of artificial intelligence (AI) ...
This whitepaper featurestechnical and product information for a variety of patient monitoring,diagnostic and therapeutic applications including: digital stethoscopes,patient monitors, ...
Pathlight™, a personalized, tumor-informed molecular residual disease (MRD) platform, will expand Foundation Medicine’s testing capabilities Pathlight uses a proprietary combination of whole genome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results